Search results
Showing 6196 to 6210 of 7681 results
This guidance has been updated and replaced by NICE guideline CG164.
Dementia: supporting people with dementia and their carers in health and social care (CG42)
This guidance has been updated and replaced by NICE guideline NG97.
This guidance has been updated and replaced by NICE guideline NG88.
Antenatal and postnatal mental health: Clinical management and service guidance (CG45)
This guidance has been updated and replaced by NICE guideline CG192.
This guidance has been updated and replaced by NICE guideline CG92.
This guidance has been updated and replaced by NICE guideline CG160.
This guidance has been updated and replaced by NICE guideline CG172.
This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.
COVID-19 rapid evidence summary: vitamin D for COVID-19 (ES28)
This evidence summary has been updated and replaced by the COVID-19 rapid guideline on vitamin D (NG187).
COVID-19 rapid evidence summary: Tocilizumab for COVID-19 (ES33)
This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.
COVID-19 rapid evidence summary: Sarilumab for COVID-19 (ES34)
This guideline has been updated and replaced by NICE COVID-19 rapid guideline NG191.
Excessive daytime sleepiness in Parkinson's disease: modafinil (ESUOM48)
This evidence summary has been updated and replaced by NICE guideline NG71.
This evidence summary has been updated and replaced by NICE evidence summary: new medicines 61.
Hormone-sensitive metastatic prostate cancer: docetaxel (ESUOM50)
This evidence summary has been updated and replaced by NICE guideline NG131.
This evidence summary has been withdrawn following updated information in the summary of product characteristics on the off-label use of sildenafil (Revatio) in neonates with persistent pulmonary hypertension of the newborn.